echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Reding Pharmaceuticals appointed Dr. Alan Sandler President and Head of Global Development in the Field of Oncology

    Reding Pharmaceuticals appointed Dr. Alan Sandler President and Head of Global Development in the Field of Oncology

    • Last Update: 2021-01-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Dr. Alan Sandler will become President of Reeding Pharmaceuticals and Head of Global Development for Oncology, with nearly 30 years of experience in oncology and drug development.
    during his tenure at Genente/Roche, he led the team in the development and approval of several innovative drugs worldwide, most recently the PD-L1 drug Tecentriq® (Tesanci®).
    joined Gene Tektronick/Roche, Dr. Sandler was a professor at Oregon Health and Science University and head of the Hematology/Oncology Department.
    , he taught at Indiana University and Vanderbilt University School of Medicine.
    Sandler holds a Ph.D. from Rush Medical School and has completed medical training and research as a researcher in oncology at Yale University-NewArkland Medical Center.
    has published more than 300 peer-reviewed publications, including articles, abstracts and chapters in books.
    note: There are deletions in the original text
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.